NFG
EBS icon

Next Financial Group’s Emergent Biosolutions EBS Stock Holding History

Next Financial Group’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$1K Hold
24
– – ﹤0.01% 2719
2021
Q3 		$1K Hold
24
– – ﹤0.01% 2599
2021
Q2 		$2K Sell
24
-170
-88% -$10.9K ﹤0.01% 2397
2021
Q1 		$18K Buy
194
+14
+8% +$1.43K ﹤0.01% 1682
2020
Q4 		$16K Buy
180
+10
+6% +$918 ﹤0.01% 1626
2020
Q3 		$18K Buy
+170
New +$18.3K ﹤0.01% 1443

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Next Financial Group's EBS Position: Q4 2021 in Review

Next Financial Group held its Emergent Biosolutions (EBS) position steady in Q4 2021 at 24 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2719.

Next Financial Group first reported a position in EBS in Q3 2020 and has held it in 6 quarters since. The position peaked at $18K in Q1 2021. 254 funds tracked by Wall St. Rank hold EBS as of Q4 2021.

  • Next Financial Group held 24 shares of Emergent Biosolutions worth $1K as of Q4 2021.
  • Next Financial Group left its Emergent Biosolutions share count unchanged in Q4 2021.
  • Emergent Biosolutions made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #2719 holding.
  • Next Financial Group first reported a position in Emergent Biosolutions in Q3 2020 and has held it in 6 quarters since.
  • Next Financial Group's Emergent Biosolutions position peaked at $18K in Q1 2021.
  • 254 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.